Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Kailera Therapeutics Inc Common Stock (KLRA)

98 + Investors. Track Smart Money conviction in KLRA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%

98+

Inst. Holders

Hedge Fund Ownership: KLRA

How many hedge funds hold KLRA — quarterly history vs. share price
Quarterly hedge fund ownership of KLRA vs. share price

Market Analysis: KLRA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: KLRA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 4 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
3.5
/ 10
conviction
Hedge Fund Positioning: KLRA
2026 Q3 Stats Unlock in 4 days 98 + Investors

Track Smart Money conviction in KLRA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 98 0 100%
13F Shares 115M 0 100%
Total Value $2.45B $0 100%
New Positions 98 0 +98
Increased Positions 0 0 -
Closed Positions 0 0 -
Reduced Positions 0 0 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: KLRA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

98 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KLRA. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 KLRA holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Royalty Pharma Sub-Manager, LLC 14.29% 2,455,357 $28.0M
2 Atlas Venture Life Science Advisors, LLC 9.36% 5,171,282 $59.1M
3 Siren, L.L.C. 0.60% 2,214,286 $25.3M
4 Axq Capital, LP 0.09% 56,864 $649K
5 Mirador Capital Partners LP 0.08% 58,284 $666K
6 Nantahala Capital Management, LLC 0.05% 140,000 $1.6M
7 Jump Financial, LLC 0.03% 381,002 $4.4M
8 Y-Intercept (Hong Kong) Ltd 0.02% 69,168 $790K
9 Exchange Traded Concepts, LLC 0.01% 260,799 $3.0M
10 Alps Advisors Inc 0.01% 171,739 $2.0M
11 Marshall Wace, LLP 0.01% 878,196 $10.0M
12 Aberdeen Group plc 0.01% 432,661 $4.9M
13 Federated Hermes, INC. 0.01% 403,693 $4.6M
14 Profund Advisors LLC 0.01% 18,880 $216K
15 Tema Etfs LLC 0.01% 13,945 $159K
16 Walleye Capital LLC 0.00% 416,853 $4.8M
17 Renaissance Technologies LLC 0.00% 198,549 $2.3M
18 Hrt Financial LP 0.00% 151,000 $1.7M
19 Los Angeles Capital Management LLC 0.00% 74,803 $854K
20 Quadrature Capital Ltd 0.00% 38,663 $442K
21 Fmr LLC 0.00% 4,659,885 $53.2M
22 Rafferty Asset Management, LLC 0.00% 53,040 $606K
23 Ameritas Investment Partners, Inc. 0.00% 4,190 $48K
24 BNP Paribas Financial Markets 0.00% 310,269 $3.5M
25 Police & Firemen's Retirement System of New Jersey 0.00% 13,618 $156K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Kailera Therapeutics Inc Common Stock (KLRA)

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →